Schwab Charles Investment Management Inc. boosted its position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 3.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 738,453 shares of the medical technology company’s stock after purchasing an additional 25,381 shares during the quarter. Schwab Charles Investment Management Inc. owned 1.11% of Hill-Rom worth $64,246,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. We Are One Seven LLC acquired a new position in Hill-Rom during the fourth quarter valued at approximately $188,000. Campbell & CO Investment Adviser LLC acquired a new position in Hill-Rom during the first quarter valued at approximately $203,000. CAPROCK Group Inc. acquired a new position in Hill-Rom during the fourth quarter valued at approximately $211,000. Braun Stacey Associates Inc. acquired a new position in Hill-Rom during the fourth quarter valued at approximately $233,000. Finally, BancorpSouth Bank acquired a new position in Hill-Rom during the fourth quarter valued at approximately $241,000. Hedge funds and other institutional investors own 84.49% of the company’s stock.
Shares of Hill-Rom opened at $89.78 on Friday, according to MarketBeat Ratings. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.36 and a current ratio of 1.85. Hill-Rom Holdings, Inc. has a twelve month low of $87.60 and a twelve month high of $89.61. The company has a market capitalization of $5.95 billion, a price-to-earnings ratio of 21.39, a P/E/G ratio of 1.37 and a beta of 0.98.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, June 22nd will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date is Thursday, June 21st. Hill-Rom’s dividend payout ratio is presently 20.73%.
A number of brokerages recently issued reports on HRC. Needham & Company LLC restated a “buy” rating and set a $106.00 price objective (up previously from $105.00) on shares of Hill-Rom in a report on Monday, April 30th. Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $99.00 price target on the stock in a research note on Thursday, January 18th. ValuEngine raised shares of Hill-Rom from a “hold” rating to a “buy” rating in a research note on Friday, March 2nd. KeyCorp reaffirmed a “buy” rating and issued a $97.00 price target on shares of Hill-Rom in a research note on Thursday, January 18th. Finally, Goldman Sachs started coverage on shares of Hill-Rom in a research note on Wednesday, April 4th. They issued a “neutral” rating and a $85.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $94.00.
In other news, SVP Deborah Rasin sold 7,590 shares of the business’s stock in a transaction on Thursday, April 12th. The shares were sold at an average price of $86.02, for a total value of $652,891.80. Following the sale, the senior vice president now owns 14,028 shares of the company’s stock, valued at $1,206,688.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.90% of the company’s stock.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.